Contact details

Alexandra Pygall

T: +44 20 7809 2137 M: +44 7881 314 566 Email Alexandra | Vcard Office: London

Awards

Intellectual property

Intellectual property

Intellectual property and pharmaceuticals and biotechnology

Intellectual property and pharmaceuticals and biotechnology

Alexandra Pygall Partner

Contact details

Alexandra Pygall

T: +44 20 7809 2137 M: +44 7881 314 566 Email Alexandra | Vcard Office: London

An intellectual property expert with significant experience of advising on both transactions and disputes. Alexandra believes in providing straightforward and practical advice in context. With degrees in both law and chemistry, many of her clients are in the life sciences sector but she also works with luxury brand clients and clients in other sectors.
  • Profile
  • Services
  • Sectors

Alexandra advises on the complete spectrum of intellectual property issues. Her clients range from life sciences companies, such as BTG plc and Vernalis plc, to luxury brand companies such as Moët Hennessy and Richemont.

Alexandra's transaction experience includes advising clients on licensing, partnering, collaboration and R&D agreements as well as on the IP aspects of mergers, acquisitions, investments (including the taking of security over IP) and commercial contracts such as manufacturing and distribution arrangements.

Her dispute experience includes advising clients in relation to claims regarding IP ownership, infringement and validity and in relation to licensing and other contractual matters. She also advises in relation to anti-counterfeiting strategies and enforcement policies. She has experience of both civil and criminal IP litigation.

Alexandra has been named in The Lawyer's Hot 100 – Dealmaker list 2019 which acknowledges her as "representative of emerging talent in the venerable City player". Described as "bright, charming, witty and solution-driven" by Chambers and Partners, she has also been described as "extremely knowledgeable and an excellent communicator who has a unique ability to demystify complex areas of law. She juggles legal business risk with opportunity and then provides robust but pragmatic advice. On top of that, she’s a huge pleasure to work with" (IAM Patent 1000, 2018). According to WTR 1000, 2019 “her enthusiasm is infectious and she has a rare ability to explain difficult issues plainly and simply for the benefit of clients and to their great advantage”. Alexandra is highly recommended for patent transactions (IAM Patent 1000), for trade mark transactions, enforcement and litigation (WTR 100 2019) and for commercial agreements and litigation concerning copyright, trade marks and life sciences patents (Chambers and Partners). She has also been awarded the Lexology Client Choice Award for healthcare and life sciences UK 2018.

“Bright, charming, witty and solution-driven"
Chambers UK 2019

  • Intellectual property

Brand protection for luxury brands such as Moët Hennessy and Richemont

Alexandra leads our specialist anti-counterfeiting team who effectively tackle counterfeit and copycat products using a strategy involving civil as well as criminal prosecution and an invaluable network of contacts within law enforcement and service providers.

Gap's sole IP counsel in the UK

Advised as part of the team on Gap's IP portfolio and, in particular, its trade mark branding issues (prosecutions, oppositions, infringements) and parallel imports.

BTG plc

Advised on the purchase of the residual financial interest (consisting of patent and related royalty payments) of the originator of the Varithena foam sclerotherapy technology for a one-off cash payment of £23 million.

Vernalis plc, an AIM-listed development stage pharmaceutical company

Advised on the out-licensing of Vernalis' worldwide rights to its proprietary adenosine receptor antagonist technology to a private US company that has raised a large Series A round. Also advised Vernalis on a number of other licensing and collaboration deals.

More: Intellectual property

  • Art and cultural property
  • Retail and luxury goods
  • Life Sciences
  • Consumer

Auction house

Advising in relation to whether a particular category of works for sale was subject to the Artist's Resale Right.

Auction house

Advised in relation to the liability for sale of a Jeff Koons painting alleged to infringe the copyright in an advertising photograph.

Auction house

Advised in relation to the potential liability for use of a third-party trade mark in a catalogue of photographs for sale.

Auction house

Advised in relation to offer for sale of an allegedly counterfeit item.

More: ​Art and cultural property

Brand protection for luxury brands such as Moët Hennessy and Richemont

Alexandra leads our specialist anti-counterfeiting team who effectively tackle counterfeit and copycat products using a strategy involving criminal as well as civil prosecution and an invaluable network of contacts within law enforcement and service providers.

Lucozade Ribena Suntory

Alexandra acts for Lucozade Ribena Suntory in relation to a variety of IP matters.

Gap's sole IP counsel in the UK

Advising as part of a team on Gap's IP portfolio and, in particular, its trade mark branding issues (prosecutions, oppositions, infringements) and parallel imports.

LEGO

Part of the team providing IP advice to the LEGO Group, including preventing misues of the client's brand and actioning takedowns on various online platforms.

More: Retail and luxury goods

Alexandra is recognised for negotiating IP-heavy deals and advising on disputes in the life sciences sector.

Examples of Alexandra's work include:

Vernalis plc

Advised this AIM-listed development stage pharmaceutical company on a number of licensing and collaboration deals, including the out-licensing of the worldwide rights to its proprietary adenosine receptor antagonist technology to a private US company that has raised a large Series A round.

UCB

Advised this global biopharma company on a variety of commercial contracts and a significant dispute with a licensing partner.

ARIAD Pharmaceuticals

Advised a specialist oncology company, headquartered in Cambridge (Massachusetts), with commercial, competition, data protection and employment advice related to its entry into the European market.

Cell Medica Ltd

Advised this cellular therapeutics company on its collaboration with Cell Therapy Catapult in relation to Cell Medica's Cytovir cytomegalovirus product and in relation to a manufacturing agreement for Cell Medica's CMD-003 product, which is under development to target malignancies associated with the oncogenic Epstein Barr virus.

More: Life sciences

Alexandra is listed in "World Trademark Review 1000 – The World’s Leading Trademark Professionals" for enforcement/litigation, anti-counterfeiting and transaction matters.

Examples of her work include:

Brand protection for luxury brands such as Moët Hennessy and Richemont

Alexandra leads our specialist anti-counterfeiting team who effectively tackle counterfeit and copycat products using a strategy involving criminal as well as civil prosecution and an invaluable network of contacts within law enforcement and service providers.

Lucozade Ribena Suntory

Alexandra acts for Lucozade Ribena Suntory in relation to a variety of IP matters.

Gap's sole IP counsel in the UK

Advising as part of a team on Gap's IP portfolio and, in particular, its trade mark branding issues (prosecutions, oppositions, infringements) and parallel imports.

More: Consumer

Awards

Intellectual property

Intellectual property

Intellectual property and pharmaceuticals and biotechnology

Intellectual property and pharmaceuticals and biotechnology

Latest news & insights

31 Oct 2019

From Insights

Understanding Brexit

Despite all the information available on Brexit, it is sometimes difficult to work out where we are in the process. This page steps back from the detail and gives an ..

More

22 May 2019

From News

Partner Alexandra Pygall named IP Star

Stephenson Harwood IP partner Alexandra Pygall has been included in the 2019 edition of Managing Intellectual Property (MIP) IP STARS Top 250 Women in IP. She is one o..

More

29 Jan 2019

From News

Alexandra Pygall named in The Lawyer's Hot 100

Stephenson Harwood partner Alexandra Pygall has been named in The Lawyer's Hot 100 - Dealmaker list.

More

04 Jun 2018

From Insights

The EU Export Manufacturing Waiver: A boost for the Generic and Biosimilar Medicines Market?

On 28 May the European Commission adopted a legislative proposal for a regulation to amend Regulation (EC) No. 469/2009 on Supplementary Protection Certificates (SPCs)..

More

19 Oct 2017

From News

Stephenson Harwood advises Novacyt SA on AIM IPO

Law firm Stephenson Harwood LLP has advised Novacyt SA on its €25 million AIM IPO.

More

25 Aug 2016

From News

Stephenson Harwood advises Cell Medica on cutting edge research and licence agreements

Law firm Stephenson Harwood LLP has advised Cell Medica Limited on a research collaboration agreement and associated option and licence agreement with University Colle..

More

25 Feb 2016

From News

Stephenson Harwood advises on £162 million IPO for Shield Therapeutics plc

Stephenson Harwood LLP has advised Shield Therapeutics plc (“Shield”) on its £162 million AIM IPO.

More

06 Jul 2014

From News

Stephenson Harwood advises on easyHotel’s IPO and admission to AIM

Stephenson Harwood LLP advised new client, easyHotel plc (easyHotel), on its upcoming placing and admission to trading on the AIM market of the London Stock Exchange.

More

22 May 2014

From News

Stephenson Harwood LLP advises on two AIM reverse takeovers

International law firm Stephenson Harwood LLP has advised on the two recent reverse takeovers of Feedback plc ("Feedback") and Rex Bionics Plc ("Rex Bionics").

More

02 Apr 2014

From News

Stephenson Harwood advises Lansen on the acquisition of Sicorten Plus

International law firm Stephenson Harwood LLP has advised Lansen Pharmaceutical Holdings Limited (Lansen) on the acquisition of the rights to sell Sicorten Plus

More

print-footer
logo
© Stephenson Harwood LLP 2016. Any reference to Stephenson Harwood in this document means Stephenson Harwood LLP and/or its affiliated undertakings. Any reference to a partner is used to refer to a member of Stephenson Harwood LLP.